MSCM
BHVN

McElhenny Sheffield Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-31
Closed -$430 – 664
2022
Q4 		$430 Buy
+31
New +$4.71K ﹤0.01% 641

Other funds holding BHVN

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return